|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1995-9-20
|
|
pubmed:abstractText |
A variant form of yeast pyruvate kinase (EC 2.7.1.40) with Ser-384 mutated to proline has been engineered in order to study the allosteric properties of this enzyme. Both the mutant and wild-type enzymes were overexpressed in a strain of yeast in which the genomic copy of the pyruvate kinase gene had been disrupted by an insertion of the Ura3 gene. Both enzymes were purified to homogeneity and their kinetic properties characterized. The wild-type enzyme displays sigmoid kinetics with respect to phosphoenolpyruvate (PEP) concentration, and is activated by the allosteric effect fructose 1,6-bisphosphate with concomitant reduction in co-operativity. In contrast, the mutant was found to be dependent on the presence of the effector for catalytic activity and was inactive in its absence. The fully activated mutant enzyme had a kcat. 1.6 times greater than that of the wild-type enzyme. The mutation introduced into the enzyme is in an intersubunit contact which is known to be critical for the allosteric properties of the enzyme, and is far removed from the active site. The major effect of the mutation seems to be to stabilize the low-affinity T state of the apoenzyme, although kcat. is also affected. The S0.5 for PEP and S0.5 for ADP of the wild-type enzyme were 0.22 +/- 0.004 and 0.15 +/- 0.01 mM respectively (means +/- S.E.M.). In the activated mutant enzyme, these kinetic parameters increased to 0.67 +/- 0.03 and 0.43 +/- 0.03 mM respectively. The cooperativity between ADP-binding sites was altered in the mutant enzyme, with the Hill coefficient (h) for ADP increasing to 1.65 +/- 0.07 in the presence of the effector, compared with a value of 0.01 +/- 0.07 for the wild-type enzyme under the same conditions. CD spectroscopy revealed the secondary structure of the mutant enzyme to be little different from that of the wild-type enzyme, indicating that the two enzymes have similar secondary structures in solution. Precise tertiary and quaternary structures such as intersubunit and interdomain interactions may be modified. An improved purification procedure has been devised that allows large quantities of enzyme to be rapidly prepared.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-1104624,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-1396575,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-14343300,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-1439821,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-1645661,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-1885610,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-2199267,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-2200166,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-2653861,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-3020052,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-3519210,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-3521596,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-3881765,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-3888784,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-4386962,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-5417407,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-5432063,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-5824555,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-6051883,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-6185493,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-6336730,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-6546423,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-7470476,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-8449346,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7646433-942051
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0264-6021
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
310 ( Pt 1)
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
117-23
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:7646433-Allosteric Regulation,
pubmed-meshheading:7646433-Chromatography, Gel,
pubmed-meshheading:7646433-Chromatography, Ion Exchange,
pubmed-meshheading:7646433-Circular Dichroism,
pubmed-meshheading:7646433-Cloning, Molecular,
pubmed-meshheading:7646433-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:7646433-Fructosediphosphates,
pubmed-meshheading:7646433-Kinetics,
pubmed-meshheading:7646433-Mutagenesis, Site-Directed,
pubmed-meshheading:7646433-Pyruvate Kinase,
pubmed-meshheading:7646433-Saccharomyces cerevisiae,
pubmed-meshheading:7646433-Spectrophotometry, Ultraviolet
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
A subunit interface mutant of yeast pyruvate kinase requires the allosteric activator fructose 1,6-bisphosphate for activity.
|
|
pubmed:affiliation |
Department of Biochemistry, University of Edinburgh, Scotland, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
